Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature

Richmond, 2010, Current indications for growth hormone therapy for children and adolescents, Endocr. Dev., 18, 92, 10.1159/000316130 Dunn, 2011, Indications for recombinant human growth hormone and evaluation of available recombinant human growth hormone devices: implications for managed care organizations, Am. J. Manag. Care, 17, eS16 Heo, 2013, Comparative proteomic analysis in children with idiopathic short stature (ISS) before and after short-term recombinant human growth hormone (rhGH) therapy, Proteomics, 13, 1211, 10.1002/pmic.201200131 Sotos, 2014, Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit, Int. J. Pediatr. Endocrinol., 15, 10.1186/1687-9856-2014-15 Poidvin, 2014, Growth hormone treatment for childhood short stature and risk of stroke in early adulthood, Neurology, 83, 780, 10.1212/WNL.0000000000000737 Sävendahl, 2012, Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, the Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study, J. Clin. Endocrinol. Metab., 97, E213, 10.1210/jc.2011-2882 Stochholm, 2018, Long-term safety of growth hormone-a combined registry analysis, Endocrinol (Oxf)., 88, 515, 10.1111/cen.13502 Ambler, 2013, Debate: idiopathic short stature should be treated with growth hormone, J. Paediatr. Child Health, 49, 165, 10.1111/j.1440-1754.2012.02465.x Albertsson-Wikland, 2016, Mortality is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics, J. Clin. Endocrinol. Metab., 101, 2149, 10.1210/jc.2015-3951 Subspecialty Group of Endocrinologic, 2013, Recommendations for the clinical use of recombinant human growth hormone in children, Zhonghua Er Ke Za Zhi, 51, 426 Juan, 2014, Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit, Int. J. Pediatr. Endocrinol., 15 Grimberg, 2016, Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth Factor-I Deficiency, Horm. Res. Paediatr., 86, 361, 10.1159/000452150 Wu, 2012, Effect of recombinant human growth hormone therapy on idiopathic short stature patients: 12 months follow-up, Chin. J. Evidence-based Pediatr., 7, 63 Zhao, 2016, The efficacy of rhGH treatment on 45 children with growth hormone deficiency and idiopathic short stature, Maternal Child Health Care China, 31, 1300 Ismail, 2011, Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy, Indian J. Hum. Genet., 17, 218, 10.4103/0971-6866.92102 Toumba, 2014, Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential, J. Pediatr. Endocrinol. Metab., 27, 311, 10.1515/jpem-2013-0210 Takeda, 2010, Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation, Health Technol. Assess., 14, 1, 10.3310/hta14420 Zheng, 2014, Effects of rhGH replacement therapy on glucose and lipid metabolism and thyroid function in children with idiopathic short stature, Chin. J. Contemp. Pediatr., 16, 1236 Ross, 2015, Attaining genetic height potential: Analysis of height outcomes from the answer program in children treated with growth hormone over 5 years, Growth Hormon. IGF Res., 25, 286, 10.1016/j.ghir.2015.08.006 Kamp, 2002, High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature, Arch. Dis. Child., 87, 215, 10.1136/adc.87.3.215 Deodati, 2011, Review of growth hormone randomized controlled trials in children with idiopathic short stature, Horm. Res. Paediatr., 76, 40, 10.1159/000330157 Moore, 2008, Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study, Pediatr. Endocrinol. Rev., 6, 5 Kriström, 2014, IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children, J. Clin. Endocrinol. Metab., 99, 2917, 10.1210/jc.2014-1101